Lindergård B, Johnell O, Nilsson B E, Wiklund P E
Nephron. 1985;39(2):122-9. doi: 10.1159/000183355.
Bone morphological parameters of renal osteodystrophy such as abundance of osteoid surface, osteoid seam width index, calcification fronts, osteoclast activity and trabecular bone volume were studied in 71 patients on maintenance hemodialysis and compared with bone densitometry, laboratory and clinical data. Increased osteoclast activity (hyperparathyroidism) was by far the most common bone morphological finding. Patients with chronic pyelonephritis or polycystic kidney disease had more than double the amount of osteoid than patients with chronic glomerulonephritis. The trabecular bone volume seemed to be increased in most patients in contrast to the cortical bone volume which was decreased, judged from bone densitometry and previously from X-ray. Despite that patients with polycystic kidney disease were older, their trabecular volume was larger than in patients with glomerulonephritis. The bone mineral content evaluated by bone densitometry was low in most patients, and more associated with bone morphological signs of osteomalacia than with secondary hyperparathyroidism. Serum phosphate (S-PO4) and serum parathyroid hormone (S-PTH) seemed to discriminate better between osteomalacia and secondary hyperparathyroidism than serum alkaline phosphatase (S-Alk. phosph.), which was elevated in both groups. Patients who had been bilaterally nephrectomized were no more abnormal than other patients, and they had lower S-Alk. phosph. The abundance of osteoclasts was found to be a predictor of future development of clinical secondary hyperparathyroidism.
对71例维持性血液透析患者的肾性骨营养不良的骨形态学参数进行了研究,如类骨质表面丰度、类骨质缝宽度指数、钙化前沿、破骨细胞活性和小梁骨体积,并与骨密度测定、实验室及临床数据进行了比较。破骨细胞活性增加(甲状旁腺功能亢进)是迄今为止最常见的骨形态学表现。慢性肾盂肾炎或多囊肾病患者的类骨质量是慢性肾小球肾炎患者的两倍多。根据骨密度测定以及之前的X线检查判断,大多数患者的小梁骨体积似乎增加,而皮质骨体积减少。尽管多囊肾病患者年龄较大,但他们的小梁骨体积比肾小球肾炎患者的大。大多数患者通过骨密度测定评估的骨矿物质含量较低,且更多地与骨软化的骨形态学体征相关,而非与继发性甲状旁腺功能亢进相关。血清磷酸盐(S-PO4)和血清甲状旁腺激素(S-PTH)在区分骨软化和继发性甲状旁腺功能亢进方面似乎比血清碱性磷酸酶(S-碱性磷酸酶)更好,后者在两组中均升高。双侧肾切除的患者并不比其他患者更异常,且他们的S-碱性磷酸酶较低。发现破骨细胞丰度是临床继发性甲状旁腺功能亢进未来发展的一个预测指标。